How Drug-Industry Lobbyists Got Their Way on Health Care

Time by Karen Tumulty, Michael Scherer | Oct. 22, 2009 (Special Report)

It's understandable the drugmakers would want a roll-call accounting of who their friends and enemies are, considering the size of the investment they are making on Capitol Hill: in the first six months of this year alone, drug and biotech companies and their trade associations spent more than $110 million — that's about $609,000 a day — to influence lawmakers, according to figures compiled by the nonpartisan watchdog group Center for Responsive ... Full Story »

Posted by Kaizar Campwala - via Ellen Miller, Huffington Post (Health Care)

See All Reviews »

View

Review

Theresa Dark
4.2
 by Theresa Dark - Oct. 25, 2009

Karen Tumulty and Michael Scherer's headline definitely grabbed my attention. The proceeding introduction (hook) into the article continued to keep my interest. The next couple of paragraphs talk about the significance of the hook and sets up the reader for the caveat. Both journalists do a good job of giving relevant points supporting the article. They also have several links providing information on pertinent data relating to the article. The conclusion of the article gives several options for its resolution depending on who wins the battle.

See All Reviews »

Theresa's Rating

Overall
4.2

Good
from 19 answers
Quality
4.1
Facts
4.0
Fairness
4.0
Information
5.0
Insight
4.0
Sourcing
3.0
Style
3.0
Accuracy
4.0
Balance
4.0
Context
5.0
Depth
4.0
Enterprise
4.0
Expertise
3.0
Originality
4.0
Relevance
5.0
Transparency
4.0
Responsibility
4.0
Popularity
4.5
Recommendation
5.0
Credibility
4.0
More How our ratings work »